9000 -- SCREEN for Type 1 Diabetes Act of 2026 | Poliscope

SCREEN for Type 1 Diabetes Act of 2026

9000

119th Congress

Health

In Committee

Legislative Progress

✓

Introduced

Committee

Floor Vote

Other Chamber

Enacted

Introduced

May 21, 2026

Latest Action

May 21, 2026

Primary Sponsor

Kim SchrierDemocratic(WA)

Momentum (last 30 days)

score

0 actions · 0 new cosponsors · 0 votes

Speed vs cohort

0pct

0d open

vs 10,940 other HR bills in the 119th — cohort avg 30d

Summary

No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.

Lobbying filings that explicitly cite this bill (4)

These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.

Filing registrants (2)

TARPLIN, DOWNS & YOUNG, LLC (2)BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) (2)

BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)client→BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)

2026 · third_quarter · Health Issues

Open original LDA filing ↗

Cited source text, amounts, lobbyists, and targets

H.R. 10227, the INSULIN Act and Issues pertaining to FDA modernization; S. 4189 - the INSULIN Act; S. 4612/H.R. 9000 - the SCREEN For T1D Act; S. 8270/H.R. 8018 - the ISLET Act; Issues pertaining to cell and gene therapies; Issues pertaining to C-peptide; Issues pertaining to NIH research; Issues pertaining to grant funding for the Special Diabetes Program; Issues pertaining to pending legislation for reclassification of deceased donor islet cells.

Client expense: $150,000 · Firm income: Not reported